Mi Guia (My Guide) pilot study

An e-Health Intervention to Improve Symptom Burden and Health-Related Quality of Life among Hispanic Women Completing Active Treatment for Breast Cancer

The Story

For Hispanic women, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death. Hispanic cancer patients in the U.S. also report worse cancer-related symptom burden and health-related quality of life than many other groups, as well as difficulty gaining access to support services due to obstacles such as cost, lack of insurance coverage, and time constraints. However, widespread smartphone use among Hispanics presents an unique opportunity for us to leverage smartphone technology to overcome these barriers.

What We’re Doing

This study aims to create and evaluate Mi Guía (My Guide), a culturally informed eHealth psychoeducational and psychosocial intervention for English or Spanish-speaking Hispanic women completing active treatment for breast cancer. Mi Guía is grounded in evidence-based paradigms to improve cancer-related symptom burden and health-related quality of life. In the first phase of the project, we will create Mi Guía and refine the intervention using usability and feasibility testing. In the second phase of the project, we will examine each component of Mi Guía for its effect on cancer-related symptom burden and health-related quality of life.

Pilot Project #2 – Research Team & Partners

  • Betina Yanez (NU)
  • Alejandra Perez-Tamayo (UIC)
  • Francisco Iacobelli (NEIU)
  • Rachel Adler (NEIU)
  • Joanna Buscemi (UIC)
  • Frank Penedo (NU)
  • Judy Guitelman (ALAS-WINGS, Community Partner)

Study Results

Study is underway. Please check back for study updates and results! Contact us to learn more or get involved.


Related Pages


Research Incubator »

Incubator and catalyst funding for partnership building, research proposal development, pilot projects, and research projects.


Community Engagement Core »

Enhancing community engagement, cancer education, survivorship support, and community capacity building.


Research Education Core »

We leverage the strengths of ChicagoCHEC institutions and partners to support students, trainees, and faculty.


Planning and Evaluation Core »

We initiate new projects and continuously evaluate ChicagoCHEC’s impact and progress toward its mission to advance cancer health equity via scientific discovery, education, training, and community engagement.


Admin Core »

The Admin Core supports ChicagoCHEC’s research, education, and outreach via overall leadership, administrative management, and program coordination.


Choose to Change Research Project »

Reducing Tobacco Use Disparities Among Adults in Safety Net Community Health Centers (The Choose to Change Study)


WeCanConnect Pilot Project »

WeCanConnect: Using mHealth to Connect Physically Disabled Cancer Patients with Matched Disabled Survivors


Latino Obesity Project »

Community-engaged obesity intervention development for Puerto Rican and Mexican men


Prostate Cancer Disparity Project »

Prostate cancer disparity in Chicago-area African American men: patient-derived models and biomarkers of cancer risk


Reducing Colorectal Cancer Disparities »

Reducing colorectal cancer disparities on the South Side of Chicago through cross-Institutional collaborations


Citizen Scientists »

Despite overall declines in rates of aggressive prostate cancer (PCa) in the U.S., racial disparity persists, with African American (AA) men experiencing rates greater than 2X those for European American (EA) men. While prostate specific antigen (PSA) screening has made a major contribution to the mortality decline, new screening strategies are needed to identify potentially […]

Breast Cancer Disparities in Chicago: Biological Factors »

The goal of this research proposal is to address the biological underpinnings of breast cancer mortality disparities in Chicago. African American (AA) women in the city have a 4-5 fold greater risk of death from hormone-dependent breast cancer compared to white women, even after controlling for stage at diagnosis, treatment, and other known prognostic factors. […]